Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE WALCZAK : revenue, balance sheet and financial ratios

PHARMACIE WALCZAK is a French company founded 6 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BEDARIEUX (34600), this company of category PME shows in 2023 a net income positive of 871 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE WALCZAK (SIREN 883796559)
Indicator 2023 2022 2021
Revenue N/C N/C N/C
Net income 870 666 € 191 767 € 402 876 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2023, PHARMACIE WALCZAK generates positive net income of 871 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2023: 403 k€ -> 871 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

870 666 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 117%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

116.57%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

41.579%

Solvency indicators evolution
PHARMACIE WALCZAK

Sector positioning

Debt ratio
116.57 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average -13 pts over 3 years

In 2023, the debt ratio of PHARMACIE WALCZAK (116.57) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
41.58% 2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average +16 pts over 3 years

In 2023, the financial autonomy of PHARMACIE WALCZAK (41.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1000.52. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1000.519

Liquidity indicators evolution
PHARMACIE WALCZAK

Sector positioning

Liquidity ratio
1000.52 2023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Excellent +11 pts over 3 years

In 2023, the liquidity ratio of PHARMACIE WALCZAK (1000.52) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of PHARMACIE WALCZAK in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of PHARMACIE WALCZAK is estimated at 10 273 402 € (range 6 247 747€ - 14 442 098€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
6247k€ 10273k€ 14442k€
10 273 402 € Range: 6 247 747€ - 14 442 098€
NAF 5 année 2023

Valuation method used

Net Income Multiple
870 666 € × 11.8x = 10 273 403 €
Range: 6 247 748€ - 14 442 099€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE WALCZAK with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE WALCZAK

What is the revenue of PHARMACIE WALCZAK ?

The revenue of PHARMACIE WALCZAK is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE WALCZAK profitable?

Yes, PHARMACIE WALCZAK generated a net profit of 871 k€ in 2023.

Where is the headquarters of PHARMACIE WALCZAK ?

The headquarters of PHARMACIE WALCZAK is located in BEDARIEUX (34600), in the department Herault.

Where to find the tax return of PHARMACIE WALCZAK ?

The tax return of PHARMACIE WALCZAK is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE WALCZAK operate?

PHARMACIE WALCZAK operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.